Baynes Roy D. - Insider Non-Derivative Transactions at Travere Therapeutics, Inc. (TVTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 8, 2024, Baynes Roy D.'s relationship to Travere Therapeutics, Inc. (TVTX) is Director, and currently has 31,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TVTX insiders.
Data Source: SEC.
Baynes Roy D. - Insider Non-Derivative Transactions of TVTX Common Stock
Baynes Roy D. - Insider Non-Derivative Transactions at TVTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 9, 2024 | Acquisition -- (Common Stock) | 6500 | 0 | 31000 |
| May 18, 2023 | Acquisition -- (Common Stock) | 4500 | 0 | 24500 |